Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 3—March 2004
Dispatch

Patient Data, Early SARS Epidemic, Taiwan

Po-Ren Hsueh*, Pei-Jer Chen*, Cheng-Hsiang Hsiao*, Shiou-Huei Yeh†, Wen-Chen Cheng*, Jiun-Ling Wang*, Bor-Luen Chiang*, Shan-Chwen Chang*, Feng-Yee Chang‡, Wing-Wai Wong§, Chuan-Liang Kao*1, Pan-Chyr Yang*1Comments to Author , and the SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital
Author affiliations: *National Taiwan University College of Medicine, Taipei, Taiwan; †National Health Research Institute, Taipei, Taiwan; ‡Tri-service General Hospital, Taipei, Taiwan; and; §Veterans General Hospital-Taipei, Taiwan

Main Article

Figure 2

Timeline of therapeutic modalities used in 10 patients with severe acute respiratory syndrome (SARS). IVIG, intravenous immunoglobulin (1 g/kg/d for 2 days). IV corticosteroid, intravenous methylprednisolone (500 mg every day for 3 days, followed by 40 mg every 8 h in patient 9 or 40 mg every 8 h in other patients for 4 to 5 days and then tapered for 1 to 2 weeks). The dosage of oral ribavirin was 2,000 mg initially, then 600 mg every 12 h (or 2,000 mg every day) for 10 days and 0.8 mg/kg every

Figure 2. Timeline of therapeutic modalities used in 10 patients with severe acute respiratory syndrome (SARS). IVIG, intravenous immunoglobulin (1 g/kg/d for 2 days). IV corticosteroid, intravenous methylprednisolone (500 mg every day for 3 days, followed by 40 mg every 8 h in patient 9 or 40 mg every 8 h in other patients for 4 to 5 days and then tapered for 1 to 2 weeks). The dosage of oral ribavirin was 2,000 mg initially, then 600 mg every 12 h (or 2,000 mg every day) for 10 days and 0.8 mg/kg every day for inhalational use. Fat arrow, date of discharge.

Main Article

1Pan-Chyr Yang and Chuan-Liang Kao contributed equally to this article.

2The SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital includes the following members: Ding-Shinn Chen, Yuan-Teh Lee, Che-Ming Teng, Pan-Chyr Yang, Hong-Nerng Ho, Pei-Jer Chen, Ming-Fu Chang, Jin-Town Wang, Shan-Chwen Chang, Chuan-Liang Kao, Wei-Kung Wang, Cheng-Hsiang Hsiao, and Po-Ren Hsueh.

Page created: June 14, 2011
Page updated: June 14, 2011
Page reviewed: June 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external